Barrett’s Oesophagus


  • Parul Dureja




1. Aldulaimi D, Jankowski J. Barrett’s oesophagus: an overview of the molecular biology. Dis Esophagus 1999; 12(3):177-80.
2. Watson A. Barrett’s oesophagus – 50 years on. Br J Surg 2000; 87(5):529-31.
3. Kumar V, Cotran RS. Basic Pathology, W.B. Saunders Company, 6th ed (USA). 1997.
4. Sampliner, RE. Practice guidelines on the diag- nosis, surveillance, and therapy of Barrett’s oesoph- agus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998; 93(7):1028-31.
5. Attwood SE, Barlow AP, Norris TK, et al. Barrett’s oesophagus: effect of anti-reflux surgery on symptom control and development of complica- tions. Br J Surg 1992; 79(10):1050-3.
6. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk fac-
tor for esophageal adenocarcinoma. N Engl J Med 1999; 340(11):825-31.
7. McDonald ML, Trastek VF, Allen MS, et al. Barrett’s esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg 1996; 111(6):1135-40.
8. Stein HJ, Kauer WK, Feussner H. Bile reflux in benign and malignant Barrett’s oesophagus: effect of medical acid suppression and Nissen fundoplica- tion. J Gastrointest Surg 1998; 2(4):333-41.
9. Sharma P. An update on strategies for eradication for Barrett’s mucosa. Am J Med 2001; 111(8a):147S-52S.
10. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treat- ment of inflammation and cancer. J Clin Invest 2001; 107(2):135-41.




How to Cite

Dureja, P. (2002). Barrett’s Oesophagus. Trinity Student Medical Journal , 3(1), Page 27–29. Retrieved from

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.